Highlights
• Pulmonary arterial hypertension (PAH) affects arteries in the lungs and in the heart
• As per the reports, this newly approved drug is therapeutically equivalent to the reference listed drug product Remodulin injection which has been developed by United Therapeuyics Corp
• After receiving this approval for its Treprostinil injection, Alembic currently has total 131 ANDA approvals (113 f....
Tags : USFDA, Alembic Pharmaceuticals, Pulmonary arterial hypertension, FDA, Remodulin, ,
comments (0)